Skip to main content
Equibles

NORTHERN TRUST CORP

Bank

Position in TCRX — TScan Therapeutics, Inc.

CIK 73124 CHICAGO, IL
Back to TCRX Full portfolio

Position in TCRX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$136,002
+$37,580 QoQ
Shares Held
138,778
+42.4% QoQ
Ownership
0.205%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 60 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TCRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. TCRX ranks #340 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,486,478 $1,235,108,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 916,467 $571,453,829
3 ALNY
Alnylam Pharmaceuticals, Inc.
 886,900 $266,983,504
4 RPRX
Royalty Pharma plc
 4,718,859 $264,586,419
5 RVMD
Revolution Medicines, Inc.
 1,117,110 $209,212,357
6 MRNA
Moderna, Inc.
 2,985,329 $209,062,587
7 INCY
Incyte Corp
 1,761,966 $199,736,460
8 CYTK
Cytokinetics Inc
 1,647,345 $140,337,319

All Filings in TCRX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $136,002 138,778
2026-03-31 $98,422 97,448
2025-12-31 $98,198 98,198
2025-09-30 $179,357 98,548
2025-06-30 $142,894 98,548
2025-03-31 $455,432 330,024
2024-12-31 $979,170 322,096
2024-09-30 $1,614,893 324,276
2024-06-30 $570,445 97,512
2024-03-31 $611,062 76,960
2023-12-31 $417,492 71,611
2023-09-30 $184,258 71,976
2023-06-30 $37,637 15,055
2023-03-31 $29,715 14,150
2022-12-31 $17,429 11,245